PUBLICATIONS

Annual report

Wemos in 2017: an overview of our activities

Annual report 2017

Annual report 2016

Infographics

2018 Financing for Health (SDG3): Shared global responsibility – an analysis of five African countries

2017 Universal Health Coverage: a pool for a plan for UHC

Human resources for health

2018 Remco van de Pas, Linda Mans, Mariëlle Bemelmans, Anja Krumeich: Framing the Health Workforce Agenda Beyond Economic Growth

2018 Factsheet ‘Introduction to Health Labour Market Analysis’

2018 Factsheet ‘Human Resources for Health: The WHO Code of Practice on the International Recruitment of Health Personnel’

2018 Factsheet ‘Human Resources for Health: Global Agreements’

2018 World Health Organization: current issues and advocacy opportunities for civil society organizations

2017 Linda Mans, Remco van de Pas, Sascha Marschang: Civil society contributions to a sustainable health workforce in the European Union (in: Public Health Panorama 2017; 3(3):357-536)

2016 Remco van de Pas, Linda Mans, e.a.: The Code of Practice and its enduring relevance in Europe and Eastern and Southern Africa

2016 Health Workers for All and All for Health Workers. Country and joint activities and project results. European project 2013-2015

2014 Health workforce shortages and international mobility in the EU

2013 Caring for carers – A relevant concern?

Good governance & Financing for health

2005 Risky remedies for the health of the poor.Global public-private initiatives in health. Report on the implementation of four GPPIs in five African countries and three Indian States

2005 Risky remedies for the health of the poor. Global public-private initiatives in health. Summary and recommendations. Report on the implementation of four GPPIs in five African countries and three Indian States

Medicines

2017 Ella Weggen and Corinne Hinlopen: ‘Independent clinical research: a road towards affordable & valuable medicines’

2017 Clinical trials in Africa: the cases of Egypt, Kenya, Zimbabwe and South Africa

2017 Pearl Heinemans, Irene Schipper, Patrick Durisch: ‘Transnational pharmaceutical companies’ clinical drug trials in Egypt: ethical questions in a challenging context’ in: Dirty Profits 5.

2016 ‘Industry-sponsored clinical drug trials: ethical questions in a challenging context’

2016 Annelies den Boer and Amy Davies: ‘Clinical trials in Africa: an exploitative relationship’ in: Dirty Profits 4.

2015 Clinical Trials Realities in Zimbabwe: Dealing with Possible Unethical Research

2015 Joint briefing paper: ”Adaptive licensing’ or ‘adaptive pathways’: deregulation under the guise of earlier access’

2014 Position paper: ‘Added Therapeutic Value: European citizens should get their money’s worth’

2014 The Clinical Trials Industry in Kenya: Realities, Risks and Challenges

2013 The Clinical Trials Industry in South Africa: Ethics, Rules and Realities

2008 A Bitter Pill: The risks of carrying out clinical drug trials in developing countries

Harmful substances

2016 Wemos and WECF: ‘Measures against endocrine disrupting chemicals: the example of Denmark, Sweden and France’